Exp Mol Med.  2017 May;49(5):e329. 10.1038/emm.2017.41.

Upregulation and biological function of transmembrane protein 119 in osteosarcoma

Affiliations
  • 1Department of Orthopedics, The Affiliated Yixing Hospital of Jiangsu University, Yixing, People's Republic of China.
  • 2Department of Orthopedics, The First Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.
  • 3Health Science Center of Jiangsu University, Zhenjiang, People's Republic of China.
  • 4Department of Cell Biology, School of Medicine, Soochow University, Suzhou, People's Republic of China.
  • 5Department of Critical Care Medicine, The Affiliated Yixing Hospital of Jiangsu University, Yixing, People's Republic of China. jnjiang245@sina.com zjgeccm@sina.com

Abstract

Osteosarcoma is suggested to be caused by genetic and molecular alterations that disrupt osteoblast differentiation. Recent studies have reported that transmembrane protein 119 (TMEM119) contributes to osteoblast differentiation and bone development. However, the level of TMEM119 expression and its roles in osteosarcoma have not yet been elucidated. In the present study, TMEM119 mRNA and protein expression was found to be up-regulated in osteosarcoma compared with normal bone cyst tissues. The level of TMEM119 protein expression was strongly associated with tumor size, clinical stage, distant metastasis and overall survival time. Moreover, gene set enrichment analysis (GSEA) of the Gene Expression Omnibus (GEO) GSE42352 dataset revealed TMEM119 expression in osteosarcoma tissues to be positively correlated with cell cycle, apoptosis, metastasis and TGF-β signaling. We then knocked down TMEM119 expression in U2OS and MG63 cells using small interfering RNA, which revealed that downregulation of TMEM119 could inhibit the proliferation of osteosarcoma cells by inducing cell cycle arrest in G0/G1 phase and apoptosis. We also found that TMEM119 knockdown significantly inhibited cell migration and invasion, and decreased the expression of TGF-β pathway-related factors (BMP2, BMP7 and TGF-β). TGF-β application rescued the inhibitory effects of TMEM119 knockdown on osteosarcoma cell migration and invasion. Further in vitro experiments with a TGF-β inhibitor (SB431542) or BMP inhibitor (dorsomorphin) suggested that TMEM119 significantly promotes cell migration and invasion, partly through TGF-β/BMP signaling. In conclusion, our data support the notion that TMEM119 contributes to the proliferation, migration and invasion of osteosarcoma cells, and functions as an oncogene in osteosarcoma.


MeSH Terms

Apoptosis
Bone Cysts
Bone Development
Cell Cycle
Cell Cycle Checkpoints
Cell Movement
Dataset
Down-Regulation
Gene Expression
In Vitro Techniques
Neoplasm Metastasis
Oncogenes
Osteoblasts
Osteosarcoma*
RNA, Messenger
RNA, Small Interfering
Up-Regulation*
RNA, Messenger
RNA, Small Interfering
Full Text Links
  • EMM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr